basimglurant (NOE-101) / Noema Pharma 
Welcome,         Profile    Billing    Logout  
 20 Diseases   2 Trials   2 Trials   74 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
basimglurant (NOE-101) / Noema Pharma
2021-001866-39: An international randomized clinical study, measuring safety and effectiveness of basimglurant for the treatment of pain in patients with Trigeminal Neuralgia Estudio clínico aleatorizado internacional, que mide la seguridad y la eficacia del basimglurant para el tratamiento del dolor en pacientes con neuralgia del trigémino

Not yet recruiting
2/3
200
Europe
basimglurant, NOE-101, Capsule
Noema Pharma, Noema Pharma AG, Noema Pharma
Trigeminal neuralgia Neuralgia del trigémino, Trigeminal neuralgia is a chronic pain condition affecting the trigeminal nerve in the face causing sudden, severe facial pain. La Neuralgia del trigémino (NT) es un dolor crónico que afecta al nervio trigémino de la cara causando dolor facial repentino e intenso., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05217628 / 2021-001866-39: An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients with Trigeminal Neuralgia.

Recruiting
2/3
200
Europe, US, RoW
Basimglurant, NOE-101, Placebo
Noema Pharma AG, Noema Pharma
Trigeminal Neuralgia
01/25
01/26
2021-000838-34: Basimglurant in children, adolescents, and young adults with Tuberous Sclerosis Complex Basimglurant in bambini, adolescenti e giovani adulti affetti da complesso della sclerosi tuberosa.

Not yet recruiting
2
67
Europe
Basimglurant, [NOE-101], Capsule, hard
Noema Pharma AG, Noema Pharma, Noema Pharma AG, Noema Pharma
Tuberous Sclerosis Complex complesso della sclerosi tuberosa, Tuberous Sclerosis Complex is a genetic disorder of uncontrolled growth of numerous benign tumors in many parts of the body including the brain, and one of the leading genetic causes of epilepsy. È una malattia genetica caratterizzata dalla crescita incontrollata di numerosi tumori benigni in molte parti del corpo, compreso il cervello, ed è una delle principali cause genetiche dell'epilessia., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05059327 / 2021-000838-34: Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

Active, not recruiting
2
61
Europe, US, RoW
Basimglurant with crossover to Placebo, Placebo with crossover to Basimglurant
Noema Pharma AG, Noema Pharma AG, Noema Pharma
Tuberous Sclerosis Complex
03/25
01/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
basimglurant (NOE-101) / Noema Pharma
2021-001866-39: An international randomized clinical study, measuring safety and effectiveness of basimglurant for the treatment of pain in patients with Trigeminal Neuralgia Estudio clínico aleatorizado internacional, que mide la seguridad y la eficacia del basimglurant para el tratamiento del dolor en pacientes con neuralgia del trigémino

Not yet recruiting
2/3
200
Europe
basimglurant, NOE-101, Capsule
Noema Pharma, Noema Pharma AG, Noema Pharma
Trigeminal neuralgia Neuralgia del trigémino, Trigeminal neuralgia is a chronic pain condition affecting the trigeminal nerve in the face causing sudden, severe facial pain. La Neuralgia del trigémino (NT) es un dolor crónico que afecta al nervio trigémino de la cara causando dolor facial repentino e intenso., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05217628 / 2021-001866-39: An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients with Trigeminal Neuralgia.

Recruiting
2/3
200
Europe, US, RoW
Basimglurant, NOE-101, Placebo
Noema Pharma AG, Noema Pharma
Trigeminal Neuralgia
01/25
01/26
2021-000838-34: Basimglurant in children, adolescents, and young adults with Tuberous Sclerosis Complex Basimglurant in bambini, adolescenti e giovani adulti affetti da complesso della sclerosi tuberosa.

Not yet recruiting
2
67
Europe
Basimglurant, [NOE-101], Capsule, hard
Noema Pharma AG, Noema Pharma, Noema Pharma AG, Noema Pharma
Tuberous Sclerosis Complex complesso della sclerosi tuberosa, Tuberous Sclerosis Complex is a genetic disorder of uncontrolled growth of numerous benign tumors in many parts of the body including the brain, and one of the leading genetic causes of epilepsy. È una malattia genetica caratterizzata dalla crescita incontrollata di numerosi tumori benigni in molte parti del corpo, compreso il cervello, ed è una delle principali cause genetiche dell'epilessia., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05059327 / 2021-000838-34: Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

Active, not recruiting
2
61
Europe, US, RoW
Basimglurant with crossover to Placebo, Placebo with crossover to Basimglurant
Noema Pharma AG, Noema Pharma AG, Noema Pharma
Tuberous Sclerosis Complex
03/25
01/26

Download Options